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Purpose: Ureaplasma colonization is related with perinatal complications in preterm infants. Little is 
known about the difference in virulence among various Ureaplasma urealyticum serovars. The aim of 
this study was to determine U. urealyticum serovars of preterm infants in order to assess whether any 
of the serovars were associated with bronchopulmonary dysplasia (BPD). 
Methods: Three hundred forty-four preterm infants with a gestational age less than 34 weeks 
admitted to Gangnam Severance Hospital neonatal intensive care unit from July 2011 to December 
2012 were included in this study. Tracheal and gastric aspirations were conducted on infants to confirm 
Ureaplasma colonization. Ureaplasma colonization was confirmed in 9% of infants, of these, serovars 
were determined by real-time polymerase chain reaction. 
Results: A total of 31 infants (gestational age, 29.3±3.1 weeks; birth weight, 1,170±790 g) were U. 
urealyticum positive. The Ureaplasma positive group treated for more days with oxygen and ventilation 
than the negative group (P<0.05). Histologic chorioamnionitis and moderate to severe BPD were more 
frequent in the Ureaplasma positive group than in the negative group (P<0.05). U. urealyticum isolates 
were either found to be a mixture of multiple serovars (32%), serovar 9 alone or combined with other 
serovars (39%), serovar 11 (26%), 2 (13%), 8 (10%), 10 (13%), and 13 (25%). No individual serovars 
were significantly associated with moderate to severe BPD and chorioamnionitis.
Conclusion: This is the first study to describe the distribution of U. urealyticum serovars from Korean 
preterm infants. Ureaplasma-colonized infants showed higher incidence of BPD and chorioamnionitis. 
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Introduction
Ureaplasma colonization has been associated with pregnancy complications, neonatal 
morbidities, and perinatal death1). Vertical transmission rates have been documented at 
45–66% in term infants and 58% in preterm infants; the lower the gestational age (GA), 
the higher the transmission rate2,3). Some reports have shown that Ureaplasma species not 
only colonize the respiratory tract but also invade the bloodstream and across the blood 
brain barrier in very low birth weight (BW) infants3,4). Ureaplasma infection is associated 
with bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), respiratory 
distress syndrome (RDS), and pneumonia and increases the risk of developing BPD by 
2.83-fold5). 
Ureaplasma has 14 known serovars that are separated into Ureaplasma parvum (serovars 
1, 3, 6, and 14) and U. urealyticum (serovars 2, 4, 5, and 7–13) biovars6). Controversy 
still remains regarding whether there are differences in virulence among the Ureaplasma 
serovars. It has been noted that some Ureaplasma serovars have a greater association 
with adverse pregnancy outcomes than others7,8). Some reports showed that Ureaplasma 
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invasiveness is likely not limited to one or a few particular 
serotypes. U. urealyticum isolates are typically found as a mixture 
of multiple serovars. A recent report has suggested that serovar 
11 alone or combined with other serovars is the most common 
serovar, and no individual species or serovars or serovar mixtures 
were associated with BPD1). It is possible that antigen variability 
and host factors may be important de ter minants for Ureaplasma 
infections rather than different serotypes; however further 
investigation is still needed. More over, there are no surveys 
regarding the serovars in Korean preterm infants.  
The aim of this study was to determine the distribution of 
Ureaplasma serovars in preterm infants in a prospective cohort 
and to assess whether any of the serovars are related to BPD.
Materials and methods
1. Study design
In prospective study, preterm infants without congenital 
anomaly, below the GA of 34 weeks that were admitted to 
the neonatal intensive care unit at the Gangnam Severance 
Hospital between July 2011 and December 2012 were enrolled. 
For 301 intubated infants, both tracheal and gastric aspirates 
were obtained for Ureaplasma culture and polymerase chain 
reaction (PCR) at birth within 24 hours of age, however, only 
gastric aspirates were obtained for 33 nonintubated infants. 
Sterile saline (0.5 mL) was instilled in the endotracheal tube and 
immediately aspirated back into the suction trap, and the process 
was repeated. The institutional review board of Gangnam 
Severance Hospital approved this study.
2. Sample collection and real-time PCR
Specimens were vortexed and 0.2 mL of each specimen was 
added to 1.8 mL of prepared 10B broth9). Tubes were incubated 
at 37°C and if a color change occurred, 0.2 mL of inoculum was 
plated onto A8 agar (Northeast Laboratory, Waterville, ME, USA). 
A positive culture was defined as a positive broth test confirmed 
by typical colony morphology on A8 agar. All remaining 
original samples and positive isolates were aliquoted and stored 
at –80°C for further DNA extraction and amplification. DNA 
was extracted using the QiAmp DNA Blood Mini kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s protocol. 
To differentiate U. urealyticum serovars, the DNA was analyzed 
by multiplex real-time PCR using the Roche LightCycler 2.0 as 
previously described10). Each primer or probe set was confirmed 
to amplify only the designated serovar and none of the other 
13 serovars when the optimized PCR conditions were used 
as described previously10). All primers were synthesized by 
Invitrogen (Carlsbad, CA, USA) and probes were manufactured 
by Roche Diagnostics (Indianapolis, IN,USA).
3. Clinical outcomes
As for comorbidities, RDS (defined by therapeutic surfactant 
treatment), patent ductus arteriosus (PDA), BPD (by National 
Institute of Health classification), necrotizing enterocolitis (NEC 
included by above stage II according to the modified Bell’s 
staging criteria), IVH (included higher than grade 2 confirmed 
by brain ultrasonography or brain magnetic resonance imaging 
[MRI]), periventricular leukomalacia (PVL confirmed by brain 
MRI), retinopathy of prematurity (ROP included above stge II 
ROPclassified according to the International Classification of 
Acute Retinopathy of Prematurity) were analyzed. Histologic 
chorioamnionitis was diagnosed as invasion of 5 more than 
polymorphonuclear cells at amnion, chorio-decidua, umbilical 
cord or chorionic plate by pathologist. Other clinical variables 
included duration of ventilator and oxygen support, duration 
of hospitalization, occurrence of preterm premature rupture of 
the membrane (defined by above 18 hours), and demographic 
variables.
Statistical analyses were conducted with the Student t test and 
chi-square analysis for means and frequencies. Numeric data are 
presented as the mean and standard deviation as the data were 
normally distributed. The Fisher exact test was used to compare 
categorical variables. Univariate odds ratios (ORs) and 95% 
confidence intervals (CIs) were calculated for the association 
of Ureaplasma species with BPD outcome. Calculations were 
performed using SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA). A 
P value less than 0.05 was considered statistically significant.
Table 1. Patient characteristics between Ureaplasma positive and 
negative groups 
Characteristic UC(+) (n=31) UC(–) (n=313) P value
Gestational age (wk) 29.3±3.1 30.5±2.1 0.563
Body weight (g) 1,170±790 1,320±650 0.089
Sex (M/F) 20/11 180/133 0.089
Apgar at 1 min 3.8±2.4 4.1±2.6 0.246
Apgar at 5 min 5.9±2.1 5.8±2.7 0.452
Cesarean section 22 (71) 198 (63) 0.124
Expire 5 (16) 8 (3) 0.245
Oxygen day (day) 48.1±35.8 41.1±38.6 0.039
Ventilator day (day) 28.0±44.2 21.2±21.7 0.041
Hospital day (day) 109.8±40.2 91.8±45.2 0.058
Antenatal steroid 28 (90) 288 (92) 0.891
Histologic chorioamnionitis 31 (100) 97 (31) 0.001
PROM 14 (45) 125 (40) 0.438
PIH 9 (29) 69 (22) 0.564
Values are presented as mean±standard deviation or number (%).
UC(+), Ureaplasma culture-positive; UC(–), Ureaplasma  culture-negative; 
PROM, preterm rupture of membrane; PIH, pregnancy induced hypertension.
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Results
A total of 344 preterm infants less than 34 weeks gestation 
were enrolled and all endotracheal and gastric aspirates were 
analyzed by culture and PCR. Thirty one (9%) preterm infants 
(GA, 29.3±3.1 weeks; BW, 1,170±790 g) were positive for 
Ureaplasma cultures, and 313 preterm infants (GA, 30.5±2.1 
weeks; BW, 1,320±650 g) were negative. There was no signifi-
cant difference of gestation and BW between the two groups. 
Ureaplasma culture-positive (UC(+)) infants were under more days 
of oxygen and ventilator treatment than Ureaplasma culture-
negative (UC(–)) infants (P<0.05) Histologic chorioamnionitis 
was confirmed more frequently in the UC(+) group than in the 
UC(–) group (100% vs. 31%, P=0.001) (Table 1). The incidence of 
common neonatal illnesses such as RDS, PDA, NEC, ROP, IVH, 
and PVL were not significantly different between the two groups. 
Moderate to severe BPD occurred more frequently in the UC(+) 
group than in the UC(–) group (68% vs. 31%, P=0.028) (Table 2). 
Serovar genotyping was performed from 31 of the UC(+) 
subjects. Ureaplasma colonization was detected inversely relative 
to the GA (OR, 0.65; 95% CI, 0.510 to 0.905, P=0.045). As shown 
in Fig. 1. U. urealyticum isolates were commonly detected as 
a mixture of multiple serovars (32%), with serovar 9 alone or 
combined with other serovars (39%) being the most common 
isolates, followed by serovar 11 (26%), 2 (13%), 8 (10%), 10 
(13%), and 13 (25%). We analyzed the correlation of Ureaplasma 
coloni zation with pulmonary outcome. No individual serovars or 
serovar mixtures were significantly associated with moderate to 
severe BPD or chorioamnionitis. 
Discussion
Recent studies have reported significant evidence that 
Ureaplasma infection may induce inflammatory processes early 
in utero and can lead to chorioamnionitis, lung injury including 
BPD, and other postnatal neonatal morbidities11-13). However, 
not much is known about the influence of Ureaplasma virulence 
factors, host immune factors, inflammatory variability, and 
interactions with environmental factors in the development of 
Ureaplasma-associated neonatal morbidities. This is the first 
study to investigate the association between Ureaplasma serovars 
and BPD in Korean preterm infants. 
Ureaplasma spp. are the most frequently isolated micro-
organisms inside the amniotic cavity during pregnancy, and 
vertical transmission in up to 50% of preterm infants and 22–55% 
of term infants has been noted2,3,14). Infection of the infant with 
Table 2. Comorbid factors between Ureaplasma positive and negative 
groups
Factor UC(+) (n=31) UC(–) (n=313) P value
RDS 27 (88) 259 (83) 0.891
PDA 9 (28) 106 (34) 0.678
BPD 25 (81) 158 (50) 0.056
BPD (≥Moderate) 21 (68) 97 (31) 0.028
NEC (≥stage II) 3 (11) 25 (8) 0.324
ROP (≥stage II) 7 (23) 94 (30) 0.395
IVH (≥GIII) 6 (19) 72 (23) 0.328
PVL 3 (10) 41 (13) 0.154
Values are presented as number (%).
UC(+), Ureaplasma  culture-positive; UC(–), Ureaplasma  culture-negative; 
RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; BPD, 
bronchopulmonary dysplasia; NEC, necrotizing enterocolitis; ROP, retinopathy 
of prematurity; IVH, intraventricular hemorrhage; PVL, periventricular leuko-
malacia.
Fig. 1. Diversity of serovars among infants colonized with Ureaplasma urealyticum. Serovars were 
detected by real-time polymerase chain reaction.
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Ureaplasma spp. may occur in utero or perinatally and has been 
related with an increased risk of chorioamnionitis, abortion, 
stillbirth, premature birth, perinatal morbidity, pneumonia, 
bacteremia, and meningitis. In a prospective cohort, 23% of 
pre term infants with Ureaplasma respiratory colonization and 
28% of infants with invasive Ureaplasma detected in the blood 
or cerebrospinal fluid were reported3). In another study, 78% 
of placentas from infants with Ureaplasma respiratory tract 
colonization showed evidence of histologic chorioamnionitis, in 
contrast to 36% of culture-negative infants1). In this study, 9% 
of preterm infants were confirmed with Ureaplasma respiratory 
colonization, and their entire placenta showed histologic 
chorioamnionitis.  
Respiratory morbidities are significantly higher in infants 
with cultured Ureaplasma. Higher mortality due to respiratory 
complications was found to be significant in colonized infants 
and the risk of a combined outcome measure of BPD or death 
due to lung disease was 4.2-fold higher in the colonized than in 
the uncolonized very low birth weight infants15,16). Among the 
infants treated with mechanically applied ventilation, those with 
positive tracheal aspirate cultures had a 7.9-fold increased risk 
to develop moderate-to-severe BPD than those with a positive 
nasopharyngeal sample alone (OR, 7.86; 95% CI, 1.31 to 47)17). In 
this study, moderate to severe BPD occurred more frequently in 
the Ureaplasma positive group. Perinatal Ureaplasma infection 
may contribute to inflammation of the lung and disruption of 
alveolar development directly or via oxidant and ventilator-
induced lung injury18,19). Therefore, the postnatal application of 
high oxygen concentrations and mechanical ventilation and the 
duration of exposure may potentiate the effects of Ureaplasma-
associated injury to the lungs1).
Recently, Ureaplasma was divided into 2 species and 14 
serovars. U. parvum, known as biovar 1, comprises serovars 1, 3, 
6, and 14, and U. urealyticum (biovar 2) comprises the remaining 
serovars 2, 4, 5, and 7–13. Ureaplasma is characterized as 
lacking a cell wall, has limited biosynthetic abilities, has a small 
genome size, and has a mucosal association in the human 
host1). In advance of the genomic sequence information for all 
14 Ureaplasma serovars, a multiplex real-time PCR assay for 
the rapid detection and discrimination of the two Ureaplasma 
biovars that targeted two conserved gene sequences in U. 
parvum or U. urealyticum was available. Compared to culture 
and traditional PCR, real-time PCR is suggested to be the most 
sensitive detection method for Ureaplasma species10,20). In this 
study, Ureaplasma serotyping was done by real-time PCR using 
serovar specific primers and probes.
Controversy remains as to whether there are differences in 
virulence among the 14 serovars and 2 biovars. For instance, 
recurrent abortions occurred 4 times more frequently in woman 
infected with serovar 4 compared with controls7). In addition, 
a report showed that pregnancy loss in mothers increased with 
a history of mean antibody titers for serovars 6 and 8 relative 
to mothers with elevated mean titers to serovars 4 and 821). 
Furthermore, some reports have suggested no difference in BPD 
rates between infants colonized with either biovar, but a higher 
rate of BPD in infants positive for both biovars8). In another report, 
a 2-fold higher rate of BPD was reported for U. urealyticum-
colonized infants than the rate for U. parvum-colonized infants8). 
Serologic responses were assessed in preterm infants with 
respiratory disease22). Elevation of titers to serovars 4, 7, and 8 was 
shown in infants with lung disease. In respiratory complications, 
the mean titers of serovars 4 and 8 were higher in nonsurvivors 
than in survivors, whereas titers to serovar 5 were elevated in 
survivors. In another study, the most common serovars alone and 
in combination with other serovars were U. parvum serovars 3 
and 6 and U. urealyticum serovar 11. Interestingly, serovars 4 and 
5 were not detected in any sample17). No correlation was found 
between BPD severity according to the serovars. In our study, 
U. urealyticum isolates were commonly found as a mixture of 
multiple serovars, and serovar 9 alone or combined was the most 
common serovar. However, there was no significant association 
between any individual or combination of serovars and the 
occurrence of BPD. 
This result is similar to reports that have shown that Urea-
plasma virulence is independent of the serovars in regard to 
the development of BPD. Due to a small sample size and the 
limitation that we only identified Ureaplasma urealyticum in 
this study, we are not able to validate the real effects of virulence 
factors on clinical severity. Further only gastric culture for U. 
urealyticum were checked for nonintubated infants. 
In conclusion, this is the first study to investigate the distri-
bu tion of U. urealyticum serovars in tracheal aspirates of 
Korean preterm infants using serovar-specific real-time PCR. 
Ureaplasma colonized infants showed a higher incidence of 
BPD and chorioamnionitis. However, none of the serovars were 
strongly associated with the occurrence of BPD in this limited 
study. Further studies to identify targets that prevent the adverse 
effects of Ureaplasma infection in the immature lung are needed. 
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